AbCellera Biologics Inc - Real-time stock metrics, market data, and comprehensive analysis
Fetching stock data...
AbCellera discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s platform integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners.
No news available
Have a question or want to work together? Fill out the form below and we’ll get back to you as soon as possible.
